Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2011-08-23
2011-08-23
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C560S042000
Reexamination Certificate
active
08003694
ABSTRACT:
The present invention provides ethyl (−)-2-[4-[2-[[1S,2R]-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-2,5-dimethylphenoxyacetate hydrochloride ¼ hydrate or a crystal thereof which can be determined by characteristic diffraction peaks of the powder X-ray diffraction, thermogravimetry-differential thermal analysis or the like, and obtained by manufacturing ethyl (−)-2-[4-[2-[[1S,2R]-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl-ethyl]amino]ethyl]-2,5-dimethylphenoxyacetate by a specific method.
REFERENCES:
patent: 2004/0229947 (2004-11-01), Yamazaki et al.
patent: 2004/0242686 (2004-12-01), Isawa et al.
patent: 2006/0135605 (2006-06-01), Tanaka et al.
patent: 1095932 (2001-05-01), None
patent: 1426355 (2004-09-01), None
patent: 1 535 897 (2005-01-01), None
patent: 2002-338513 (2002-11-01), None
patent: 03/024916 (2003-03-01), None
Supplementary European Search Report dated Jun. 30, 2010.
Isawa Hidetoshi
Toda Michio
Javanmard Sahar
Kissei Pharmaceutical Co. Ltd.
Padmanabhan Sreeni
Sughrue & Mion, PLLC
LandOfFree
Crystal of hydroxynorephedrin derivative hydrochloride... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystal of hydroxynorephedrin derivative hydrochloride..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystal of hydroxynorephedrin derivative hydrochloride... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2688002